Nur Nicholson

Companies

• Kailera Therapeutics, Inc.Chief Technology Officer Sep 9, 2026 to now¹
• Apellis Pharmaceuticals, Inc.Chief Technical Officer Oct 6, 2020 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APApellis Pharmaceuticals, Inc.0 shares³May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Returned to company 45,220 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 27,320 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 9,754 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 5,645 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 41,250 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 41,250 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 24,284 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 24,284 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 45,220 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 45,220 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Returned to company 22,610 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026Granted 22,610 shares of Apellis Pharmaceuticals, Inc.³
• May 14, 2026U 116,338 shares of Apellis Pharmaceuticals, Inc.³
• Jan 28, 2026Granted 45,220 shares of Apellis Pharmaceuticals, Inc.⁴
• Jan 22, 2026Sold 7,725 shares at $21.77 of Apellis Pharmaceuticals, Inc.⁵
• Jan 20, 2026Sold 2,203 shares at $19.79 of Apellis Pharmaceuticals, Inc.⁶
• Jan 13, 2026Sold 2,618 shares at $22.19 of Apellis Pharmaceuticals, Inc.⁷
• Jan 29, 2025Sold 825 shares at $29.52 of Apellis Pharmaceuticals, Inc.⁸
• Jan 22, 2025Sold 3,948 shares at $30.43 of Apellis Pharmaceuticals, Inc.⁹
• Jan 21, 2025Granted 36,426 shares of Apellis Pharmaceuticals, Inc.¹⁰
• Jan 17, 2025Sold 2,145 shares at $29.96 of Apellis Pharmaceuticals, Inc.¹⁰
• Jan 13, 2025Sold 2,632 shares at $28.70 of Apellis Pharmaceuticals, Inc.¹¹
• Mar 13, 2024Sold 3,452 shares at $58.13 of Apellis Pharmaceuticals, Inc.¹²
• Mar 13, 2024Sold 7,768 shares at $57.31 of Apellis Pharmaceuticals, Inc.¹²
• Jan 29, 2024Sold 835 shares at $64.14 of Apellis Pharmaceuticals, Inc.¹³